Latest Research in Cancer, Hypoxia, and Metabolism
19 research papers · 2026 median publication year
Top Research Topics in Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism — 5 papers
- Kruppel-like factors research — 1 papers
- RNA modifications and cancer — 1 papers
- Lung Cancer Diagnosis and Treatment — 1 papers
- Cancer, Lipids, and Metabolism — 1 papers
- Circular RNAs in diseases — 1 papers
- Nutrition and Health in Aging — 1 papers
- Epigenetics and DNA Methylation — 1 papers
- Metabolomics and Mass Spectrometry Studies — 1 papers
- Glycosylation and Glycoproteins Research — 1 papers
Highest-Cited Papers
- HIF1α-KLF4 signaling dictates extra-erythrocyte expression of hemoglobin conferring sorafenib resistance in hepatocellular carcinoma
- Metabolism-guided precision oncology in hepatocellular carcinoma: vascular, stromal and immune crosstalk
- Fibronectin 1 mediated histone lactylation promotes malignant progression of GIST regulated by m6A modification
- Longitudinal PET/CT-Derived Body Composition Changes During Systemic Therapy in Patients with Lung Cancer
- Glycolipid metabolic crosstalk in tumor immune evasion and therapeutic targeting
- TRIM21-dependent ubiquitination of MCCase induced by hsa_circ_0009061 drives H3K36 crotonylation to suppress epithelial ovarian cancer progression through regulating glycolysis
- Spatiotemporal Multi‐Omic Mapping Reveals Liver‐Muscle Metabolic Crosstalk in Cancer Cachexia
- Clinical Effect of the Warburg Effect in Stage IV Hepatocellular Carcinoma
- SUCLG2 demethylates GADD45G to activate the p53 pathway and inhibit malignant progression in colorectal cancer
- 1 H HR‐MAS NMR Metabolomics in Combination With Transcriptomic Correlation Provides New Insights Into Metabolic Heterogeneity Across Breast Cancer Immunohistochemical Subtypes
- MUC13 promotes cisplatin resistance in intrahepatic cholangiocarcinoma through regulation by histone H3K18 lactylation
- Metabolic reprogramming-mediated therapeutic resistance in renal cell carcinoma: Mechanisms and targeted intervention strategies
- LZTR1 deficiency reprograms mitochondria via mtTFA stabilization to drive OXPHOS-dependent stemness and progression in HCC
- XRCC4 glutarylation promotes its degradation to sensitize breast cancer cells to PARP inhibitors
- l-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial
- AARS1‐Mediated H3K27 Lactylation Rewires Glycolysis to Sustain Aggressive and Recurrent Bladder Cancer
- Nuclear Pan‐Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma
- GRP78/BiP as a novel midbody component induces mitotic exit failure via PLK1 stabilization in hepatocellular carcinoma
- GSDME deficiency enhances neutrophil recruitment and exacerbates irinotecan-induced intestinal mucositis